What is it used for?
ISTURISA is indicated for the treatment of endogenous hypercortisolemia in adults with Cushing's syndrome for whom surgery is not an option or has not been curative.ISTURISA is indicated for the treatment of endogenous hypercortisolemia in adults with Cushing's syndrome for whom surgery is not an option or has not been curative.
Read the primary sourceThis source does not establish current stock, import permission or personal eligibility in China. The treating clinician and provider must confirm these separately.
Product details
- Active ingredient
- osilodrostatosilodrostat
- Form and strength
- TABLET, COATED · 1 mg; TABLET, COATED · 5 mg; TABLET, COATED · 10 mgTABLET, COATED · 1 mg; TABLET, COATED · 5 mg; TABLET, COATED · 10 mg
- Manufacturer / applicant
- RECORDATI RARE DISEASES, INC.RECORDATI RARE DISEASES, INC.
ISTURISA is available as: 1 mg tablets: Pale yellow, unscored, round, biconvex with beveled edge tablet, debossed "1" on one side. 5 mg tablets: Yellow, unscored, round, biconvex with beveled edge tablet, debossed "5" on one side.ISTURISA is available as: 1 mg tablets: Pale yellow, unscored, round, biconvex with beveled edge tablet, debossed "1" on one side. 5 mg tablets: Yellow, unscored, round, biconvex with beveled edge tablet, debossed "5" on one side.
Safety and clinical review
- HypocortisolismHypocortisolism
- QTc ProlongationQTc Prolongation
- Elevations in Adrenal Hormone Precursors and AndrogensElevations in Adrenal Hormone Precursors and Androgens
Ask your clinician to review the complete label, medical history, other medicines, allergies, pregnancy or breastfeeding and any required monitoring. Do not start, stop or change treatment from this page.
Read the primary sourcePrepare your enquiry
Include the brand or generic name, strength, dosage form, requested quantity and country where care is needed. You can attach a prescription when you continue.
Questions patients ask
What is ISTURISA used for?
ISTURISA is indicated for the treatment of endogenous hypercortisolemia in adults with Cushing's syndrome for whom surgery is not an option or has not been curative.ISTURISA is indicated for the treatment of endogenous hypercortisolemia in adults with Cushing's syndrome for whom surgery is not an option or has not been curative.
This source does not establish current stock, import permission or personal eligibility in China. The treating clinician and provider must confirm these separately.
Which formulation of ISTURISA should I ask about?
TABLET, COATED · 1 mg; TABLET, COATED · 5 mg; TABLET, COATED · 10 mgTABLET, COATED · 1 mg; TABLET, COATED · 5 mg; TABLET, COATED · 10 mg
Read the primary sourceWhat determines the price of ISTURISA?
A current quote depends on the exact presentation, quantity, provider and access arrangements. A catalogue entry is not a stock or delivery promise. Medical charges are paid to the provider, separately from coordination fees.
What should I check before using ISTURISA?
Ask your clinician to review the complete label, medical history, other medicines, allergies, pregnancy or breastfeeding and any required monitoring. Do not start, stop or change treatment from this page.
Sources and review scope
FDA prescribing informationThis source does not establish current stock, import permission or personal eligibility in China. The treating clinician and provider must confirm these separately.